ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier
As the secular bull market takes a short-term pause, now is the time to research tremendous opportunities that lie ahead. I’ve
In this StockCharts TV video, Mary Ellen reveals what took place last week and how the markets closed. She also revealed what drove
Bitcoin reached new heights this week, then paused amid speculation about how high it could go. Meanwhile, the Biden administration finalized a multibillion-dollar
The Biden administration has announced a strategic roadmap to significantly expand the United States’ nuclear energy capacity, setting a target to triple
In a recent interview with Alvopetro Energy (TSXV:ALV,OTCQX:ALVOF) President and CEO Corey Ruttan, he expressed confidence that his company is set to